Results 181 to 190 of about 18,651 (251)

Exogenous glutamate potentiates gentamicin to kill multidrug- and carbapenem-resistant <i>Pseudomonas aeruginosa</i> by activating the biosynthesis of unsaturated fatty acids. [PDF]

mSystems
Lai H-F, Pan L, Song K-Y, Dai Z-Y, Liang Y, Yuan W, Chen Z-G, Yang L-F.   +7 more
europepmc   +1 more source

The Deep Mining Era: Genomic, Metabolomic, and Integrative Approaches to Microbial Natural Products from 2018 to 2024. [PDF]

Mar Drugs
Wang Z, Yu J, Wang C, Hua Y, Wang H, Chen J.   +5 more
europepmc   +1 more source

Reaction of Oxazoles with Dienophiles

Chemical and Pharmaceutical Bulletin, 1966
T, Naito, T, Yoshikawa
openaire   +3 more sources

Crystal structure and Hirshfeld-surface analysis of an etoxazole metabolite designated R13. [PDF]

Acta Crystallogr E Crystallogr Commun
Mohan Kumar TM, Bhaskar BL, Priyanka P, Divakara TR, Yathirajan HS, Parkin S.   +5 more
europepmc   +1 more source

Intrinsic mechanical properties of two-dimensional covalent organic frameworks. [PDF]

Chem Sci
Xiong L, Fu C, Tian J, Geng Y, Han L, Zhang H, Li H.   +6 more
europepmc   +1 more source

Synthesis of extended oxazoles II: reaction manifold of 2-(halomethyl)-4,5-diaryloxazoles

, 2016
Pravin C. Patil, Frederick A. Luzzio
openalex   +2 more sources

A high-resolution data set of fatty acid-binding protein structures. III. Unexpectedly high occurrence of wrong ligands. [PDF]

Acta Crystallogr D Struct Biol
Ehler A, Bartelmus C, Benz J, Plitzko I, Rudolph MG.   +4 more
europepmc   +1 more source

STUDIES OF ACUTE TOXICITY OF OXAZOLE CONTAINING PEPTIDOMIMETICS AT INTRAGASTRIC ADMINISTRATION

, 2016
Kateryna Sedko, Iryna Nizhenkovska, В. С. Броварец, A.V. Golovchenko   +3 more
openalex   +1 more source

Methyl 2,2′-dimethyl-4′-[2-(methylsulfanyl)ethyl]-1,3-dioxo-2,3-dihydro-1H,4′H-spiro[isoquinoline-4,5′-oxazole]-4′-carboxylate

, 2011
Hoong‐Kun Fun, Ching Kheng Quah, Chengmei Huang, Haitao Yu   +3 more
openalex   +1 more source

Discovery of Novel Piperidinyl-Based Benzoxazole Derivatives as Anticancer Agents Targeting VEGFR-2 and c-Met Kinases. [PDF]

Pharmaceuticals (Basel)
Eldehna WM, Elsayed ZM, Elnagar MR, El-Said AH, Majrashi TA, Negmeldin AT, Saleh AM, Elrayess R, Elnahriry KA, Chen ZL, Elagawany M, Tawfik HO.   +11 more
europepmc   +1 more source